Exceptional science attracts leading researchers, collaborators, and business leaders—experts who are able and eager to improve human health and enrich life on this planet. At Viotika Life Sciences, we have assembled such a team, including:
Charles (Chuck) LaFlèche, FCPA, FCMA
President, Chief Executive Officer, and Chief Financial Officer
Winnipeg, Manitoba
Experienced entrepreneur, CEO, and finance leader with experience in health informatics software, life sciences, aquaculture, and non-profit enterprises.
Dr. Dominic Ryan
Chief Scientific Officer
Littleton, Massachusetts
Seasoned CSO with significant experience in large pharma and biotech research.
Dr. Peter Bernstein
Medicinal Chemist
Philadelphia, Pennsylvania
A respected Medicinal Chemist and thought leader with over 30 years of experience in drug development.
Dr. Tom Dougherty
Scientific Advisor
Ayer, Massachusetts
A leading expert in AMR and Neisseria gonorrhea, and a former Research Scientist, Department of Microbiology, at Harvard Medical School.
Dr. Blanca Barquera
Researcher and NQR Expert
Troy, New York
A Professor of Biological Sciences at Rensselaer Polytechnic Institute, and a leading expert in NQR, the protein at the centre of Viotika’s work.
Rita Groleau
Winnipeg, Manitoba
Administrative Assistant
Over 30 years of administrative leadership experience in banking, software, and the non-profit sector.
Viotika has entered into a strategic partnership with Evotec SE (https://www.evotec.com/en), a German-based contract research organization that will provide a 10-person science team to advance the work and prepare for animal trials and market entry. Evotec operates in six countries and has established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development.